Oncology Institute (NASDAQ:TOI – Get Free Report) and Alignment Healthcare (NASDAQ:ALHC – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, dividends, risk, analyst recommendations, earnings and valuation.
Volatility and Risk
Oncology Institute has a beta of 0.14, suggesting that its share price is 86% less volatile than the S&P 500. Comparatively, Alignment Healthcare has a beta of 1.16, suggesting that its share price is 16% more volatile than the S&P 500.
Valuation & Earnings
This table compares Oncology Institute and Alignment Healthcare”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Oncology Institute | $393.41 million | 0.67 | -$64.66 million | ($0.64) | -4.19 |
| Alignment Healthcare | $2.70 billion | 1.54 | -$128.04 million | ($0.12) | -173.00 |
Oncology Institute has higher earnings, but lower revenue than Alignment Healthcare. Alignment Healthcare is trading at a lower price-to-earnings ratio than Oncology Institute, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
36.9% of Oncology Institute shares are held by institutional investors. Comparatively, 86.2% of Alignment Healthcare shares are held by institutional investors. 8.5% of Oncology Institute shares are held by company insiders. Comparatively, 6.6% of Alignment Healthcare shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares Oncology Institute and Alignment Healthcare’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Oncology Institute | -13.21% | -1,527.21% | -35.30% |
| Alignment Healthcare | -0.57% | -16.23% | -2.20% |
Analyst Recommendations
This is a summary of current ratings and price targets for Oncology Institute and Alignment Healthcare, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Oncology Institute | 1 | 0 | 3 | 1 | 2.80 |
| Alignment Healthcare | 1 | 3 | 9 | 1 | 2.71 |
Oncology Institute currently has a consensus price target of $6.50, indicating a potential upside of 142.54%. Alignment Healthcare has a consensus price target of $23.32, indicating a potential upside of 12.32%. Given Oncology Institute’s stronger consensus rating and higher possible upside, equities analysts clearly believe Oncology Institute is more favorable than Alignment Healthcare.
Summary
Alignment Healthcare beats Oncology Institute on 9 of the 14 factors compared between the two stocks.
About Oncology Institute
-logo-1200x675.png?v=20220303080937){kind=logo}
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
About Alignment Healthcare
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Receive News & Ratings for Oncology Institute Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Institute and related companies with MarketBeat.com's FREE daily email newsletter.
